A material transfer agreement (MTA) is a legally binding agreement between two parties (a “provider” and a “recipient”) for the unfunded transfer of tangible research assets to be used for the ...

Material Transfer Agreements. Material Transfer Agreement Information Sheet (MTA Info Sheet): MTA Info Sheet The MTA Info Sheet must be completed by the Purdue Principal Investigator (PI) in charge of ...

A Material Transfer Agreement (MTA) governs the transfer of biological, chemical, archeological and other materials from one organization to another. Usually the materials in question are proprietary ...

VICTORIA, British Columbia & ZHUHAI, China, October 02, 2024--ImmunoPrecise Antibodies Ltd. (the "Company" or "IPA") (NASDAQ: IPA), an AI-driven biotherapeutic research and technology company, and ...

Enterprise & Innovation utilizes several types of contractual agreements for University and external users. Find information for non-disclosure agreements and material transfer agreements.

KELOWNA, BC / ACCESSWIRE / September 3, 2024 / Lexaria Bioscience Corp. (NASDAQ:LEXX)(NASDAQ:LEXXW) (the "Company" or "Lexaria"), a global innovator in drug delivery platforms announces that it ...

ImmunoPrecise Subsidiary Signs Material Transfer ... The transfer of this therapeutic asset to Biotheus aims to ... as discussed in the Company’s Annual Report on Form 20-F for ...

Under this agreement, Biotheus will receive a specialized antibody asset from Talem Therapeutics, a subsidiary of ImmunoPrecise Antibodies. Biotheus plans to use this asset in conjunction with its ...